Montara Therapeutics is a preclinical-stage biopharmaceutical company pursuing novel approaches to develop safer and more efficacious treatments for neurological diseases. Montara's BrainOnly™ platform enables brain-specific pharmacology by leveraging existing and novel chemical warheads, restricting deleterious on-target / off-tissue peripheral activity.
Market
CNS diseases
Location
San Francisco,
California,
USA
Coinvestors
SV Health Investors' Dementia Discovery Fund, Two Bear Capital, Dolby Family Ventures, KdT Ventures, BEVC